Skip to content

Published 1 Oct 2019· via Microsoft· Press release

Novartis and Microsoft: Transforming Medicine with Artificial Intelligence

Novartis · Pharma · Switzerland

Headline result

The source does not publish a single comparable figure. Reported results are listed below.

Summary

Novartis and Microsoft formed a multi-year strategic alliance to establish the Novartis AI Innovation Lab in Switzerland.

The collaboration aims to bring AI capabilities to every Novartis employee and tackle hard computational problems in life sciences, including generative chemistry, image analysis for personalized therapies, and optimization of cell and gene therapies.

The problem

  1. 01Transform medicine discovery, development, and commercialization using AI.
  2. 02Address major computational challenges in life sciences.
  3. 03Slow and costly drug discovery processes hamper delivery of new treatments.
  4. 04Clinical trial efficiency and patient accessibility need major improvements.
  5. 05Manufacturing next-generation therapies requires advanced data-driven processes.
  6. 06Employees lack accessible tools for AI-driven insights without extensive data science expertise.
  7. 07Large, siloed scientific datasets are underutilized for R&D breakthroughs.

What they built

  1. 01Established the Novartis AI Innovation Lab.
  2. 02Combined Novartis datasets with Microsoft AI solutions and Azure cloud technologies.
  3. 03Set up joint research activities in Switzerland, Ireland, and the UK.
  4. 04Established an AI Innovation Lab to experiment and scale AI adoption in pharma workflows.
  5. 05Integrated Microsoft Azure AI, Azure ML, and Azure OpenAI services into R&D and manufacturing processes.
  6. 06Developed machine learning-powered platforms (e.g., data42) to pattern-match across vast company data.
  7. 07Embedded AI tools for routine work—from image analysis to digital clinical trials—supporting all employees.
  8. 08Co-development of digital therapeutics and remote clinical trials increases trial reach and accessibility.

Reported results

  1. 01The press release says the alliance will help accelerate discovery and development of transformative medicines and unlock new insights.
  2. 02It also says Microsoft AI could help reduce patient costs and bring AI capabilities to every Novartis employee.
  • Accelerated medicine discovery and development
  • Brought AI capabilities to every associate

Source

Microsoft

Press release · 1 Oct 2019 · Published by a vendor

Read the original(opens in a new tab)

How this deployment compares

Computed from the library · data 10 Nov 2026

Novartis has 3 deployment records in the library, from 2019 to 2021. It is one of 7 generative AI transformation deployments, 1 of them in Pharma.

Novartis in the library

3 deployment records from Novartis, 2019–2021

  1. Sept 2019Novartis and Microsoft revolutionize healthcare with AI-driven collaborationTherapeutics research
  2. Oct 2019This record · Generative AI transformation
  3. Nov 2021Novartis revolutionizes drug discovery with Microsoft Azure AITherapeutics research
How Novartis uses AI: company page

Same pattern, whole library

One of 7 generative AI transformation deployments

  • Pharma accounts for 1 of them (14%), ranking #2 of 6 industries.
  • It predates the pattern's recent wave: 5 records have been published since Oct 2023.
  • Only 1 of the 7 put a number on the result (14%).
Provider mix
  • AWS43%
  • GCP29%
  • Microsoft14%
  • Alibaba14%
Most-used technology
  • Amazon Bedrock 3
  • Anthropic Claude 3 3
  • Azure 1
  • Microsoft AI 1
  • Azure AI 1
  • Azure ML 1

Outlined: used in this record.

Shares describe this library, not the whole market.

Generative AI transformation analysis

How we checked this record

Evidence tier: collected

Source-linked, but not yet corroborated by a primary source.

Named organization
Novartis
Who published the source
The technology vendor
Deployment status
The source does not say
Quantified result
The source reports no figure
Summary checked against source
4 / 5 agreement

Last re-checked 26 Jul 2026.

This record is evidence for

Insight · industryPharma dossierOne of 97 Pharma deployments. See which patterns dominate there and what they report.Insight · patternGenerative AI transformation7 deployments share this pattern. See where it is used and how it is built.Trend · momentumBuilding pattern5 new deployments in the last six months, against 0 in the six before.

Same pattern, other organizations

All generative ai transformation deployments
  1. 20 Aug 2026
    Finance

    Nomura uses Llama models in Amazon Bedrock to democratize generative AI

    Nomura · Generative AI transformation · AWS

    Nomura uses Llama models from Meta through Amazon Bedrock to democratize generative AI across the financial institution. The implementation supports enterprise experimentation and deployment of generative-AI capabilities, including text summarization.

  2. 1 Aug 2026
    Tech & Comms

    TELUS Fuel iX built on Vertex AI to deploy thousands of custom generative AI solutions

    TELUS · Generative AI transformation · GCP

    TELUS built Fuel iX, a secure generative AI platform on Google Cloud that lets employees choose from 40+ AI models, with 90% of model traffic running through Vertex AI. Fuel iX is embedded into tools like Google Chat and Slack, powers a customer support tool, and supports parallel and multi-tool calling with Claude and Gemini. TELUS reports 47 large-scale gen AI products, 13,000+ custom AI solutions, 500,000+ hours saved, and 30% faster code shipping.

    +30%
    product development speed
  3. 27 Jul 2026
    Education

    CACTUS Communications accelerates idea-to-prototype for generative AI on Amazon Bedrock

    CACTUS Communications · Generative AI transformation · AWS

    CACTUS Communications built highly scalable generative AI-powered services on Amazon Bedrock for its academic publishing and research products. The company deployed Amazon Bedrock into an existing AWS stack to accelerate development of more than 20 generative AI use cases while protecting unpublished research and controlling costs.

    Production

  4. 24 Jul 2026
    Consumer & Food

    Mars — Gemini Enterprise Agent Platform for agentic campaign creation and workforce automation

    Mars · Generative AI transformation · GCP

    Mars, Inc. is a global $65 billion family-owned consumer goods company with a highly federated operating model and fragmented legacy systems. The company partnered with Google Cloud to adopt Gemini Enterprise as a primary AI operating system and migrated One Demand AI to Gemini Enterprise Agent Platform to provide governed access to specialized agents across business units. Brand teams use campaign brief agents to synthesize brand intelligence and market research into approved briefs, and Mars is launching additional agents for trend identification and ecommerce recommendations.

    Multi-agent

    62K count
    associates enabled with agentic capabilities